Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts

por Bozec, A, Formento, P, Lassalle, S, Lippens, C, Hofman, P, Milano, G
Publicado 2007

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126

por Bozec, A, Lassalle, S, Gugenheim, J, Fischel, J-L, Formento, P, Hofman, P, Milano, G
Publicado 2006

Reply: Did animal offer relevant model for bevacizumab testing?

por Bozec, A, Sudaka, A, Fischel, J L, Brunstein, M C, Grimaldi, M C, Milano, G
Publicado 2008

Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model

por Bozec, A, Sudaka, A, Fischel, J-L, Brunstein, M-C, Etienne-Grimaldi, M-C, Milano, G
Publicado 2008

French consensus on management of head and neck cancer surgery during COVID-19 pandemic

por Fakhry, N., Schultz, P., Morinière, S., Breuskin, I., Bozec, A., Vergez, S., de Garbory, L., Hartl, D., Temam, S., Lescanne, E., Couloigner, V., Barry, B.
Publicado 2020

Consensus français sur la pratique de la chirurgie oncologique ORL pendant la pandémie de COVID-19()

por Fakhry, N., Schultz, P., Morinière, S., Breuskin, I., Bozec, A., Vergez, S., de Garbory, L., Hartl, D., Temam, S., Lescanne, E., Couloigner, V., Barry, B.
Publicado 2020